| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Hong Kong | 3 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Japan | 2 | |
| #4 | Brazil | 1 | |
| #5 | Canada | 1 | |
| #6 | EAPO (Eurasian Patent Organization) | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Organic chemistry methods | |
| #3 | Acyclic or carbocyclic compounds | |
| #4 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Alken Rudolf-Giesbert | 9 |
| #2 | Schneider Frank | 8 |
| #3 | Rudolf-Giesbert Alken | 1 |
| #4 | Alken Rudolf Giesbert | 1 |
| #5 | Schneider Frank F | 1 |
| #6 | Frank Schneider | 1 |
| #7 | Alken Rudolf-Giesbert R-G | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EA028931B1 | Composition comprising catecholamine derivatives including l-2-amino-2,3,3-trideutero-3-(3,4-dihydroxyphenyl) and l-2-amino-2,3-dideutero-3-(3,4-dihydroxyphenyl) or physiologically acceptable salts thereof and use of the composition for treating parkinson's disease, restless leg syndrome, amyotrophic lateral sclerosis and multiple system atrophy |